Expertise in
4
conditions

Peter G. Colman

Melbourne, VIC, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Peter Colman practices in Melbourne, Australia. Mr. Colman is highly rated in 4 conditions, according to our data. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Kidney Transplant.

His clinical research consists of co-authoring 121 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Melbourne, VIC, Australia
Other Locations
Parkville, VIC, Australia
Parkville, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
A Randomised Trial to Evaluate the Efficacy on Retinopathy and Safety of Fenofibrate in Adults With Type 1 Diabetes. A Multicentre Double-blind Placebo-controlled Study in Australia and Internationally.
Enrollment Status: Recruiting
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fenofibrate
Study Phase: Phase 3
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
A User Evaluation of the MiniMed® 640G Insulin Pump and Guardian® Link Transmitter
A User Evaluation of the MiniMed® 640G Insulin Pump and Guardian® Link Transmitter
Enrollment Status: Completed
Publish Date: May 15, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 3 Less Clinical Trials

121 Total Publications

Early electronic specialist-led diabetes care improves post-discharge glycaemia: the STOIC-D Surgery follow-up cohort.
Early electronic specialist-led diabetes care improves post-discharge glycaemia: the STOIC-D Surgery follow-up cohort.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Colman's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile